- Home
- BDX vs MET Comparison
BDX vs MET Comparison
Compare BDX & MET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BDX | MET |
|---|---|---|
| Founded | 1897 | 1863 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.5B | 50.1B |
| IPO Year | 1962 | N/A |
Fundamental Metrics
Financial Performance| Metric | BDX | MET |
|---|---|---|
| Price | $176.39 | $77.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | ★ $189.60 | $96.08 |
| AVG Volume (30 Days) | 2.7M | ★ 4.1M |
| Earning Date | 02-09-2026 | 02-04-2026 |
| Dividend Yield | 2.39% | ★ 2.94% |
| EPS Growth | ★ 3.08 | N/A |
| EPS | ★ 6.12 | 4.71 |
| Revenue | $21,924,000,000.00 | ★ $77,084,000,000.00 |
| Revenue This Year | $3.16 | $1.96 |
| Revenue Next Year | $3.12 | $3.71 |
| P/E Ratio | $28.72 | ★ $16.41 |
| Revenue Growth | 6.22 | ★ 8.60 |
| 52 Week Low | $162.29 | $65.21 |
| 52 Week High | $235.34 | $87.39 |
Technical Indicators
Market Signals| Indicator | BDX | MET |
|---|---|---|
| Relative Strength Index (RSI) | 32.53 | 48.46 |
| Support Level | $164.41 | $75.70 |
| Resistance Level | $182.75 | $79.60 |
| Average True Range (ATR) | 6.17 | 2.15 |
| MACD | -3.75 | 0.12 |
| Stochastic Oscillator | 23.59 | 35.74 |
Price Performance
Historical ComparisonAbout BDX Becton Dickinson and Company
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.
About MET MetLife Inc.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.